SEC Launches Probe Into Private Equity Continuation Vehicles

The U.S. Securities and Exchange Commission has initiated an investigation into the rapidly growing use of "continuation vehicles" by private equity firms, according to a Reuters report published on June 24. The probe signals heightened regulatory scrutiny of these complex transactions, which allow firms to retain control of prized assets for extended periods and have become a dominant feature of the private markets.

Continuation vehicles, or CVs, are special-purpose funds created by a private equity sponsor, also known as the general partner (GP), to acquire one or more assets from one of the GP’s own older funds. This maneuver effectively allows the GP to extend its ownership beyond the typical 10-year fund lifecycle, resetting the clock on an investment it believes still has significant growth potential. The surge in these deals is a direct response to a challenging exit environment. With markets for initial public offerings and traditional mergers and acquisitions remaining sluggish, GPs have turned to CVs to provide liquidity to investors in their older funds without being forced to sell a high-performing company at a suboptimal price.

This trend, while offering a practical solution for general partners wanting to hold onto winning assets, introduces a new layer of complexity and potential misalignment for investors and the portfolio companies themselves. For investors, known as limited partners (LPs), in the original fund, the transaction presents a choice: they can either sell their stake and receive a cash distribution or “roll over” their interest into the new continuation vehicle to participate in the asset’s future growth.

The core of the SEC's concern, according to market observers, lies in the inherent conflict of interest embedded in these transactions. The GP is effectively on both sides of the deal—acting as the seller on behalf of the original fund's investors and as the buyer on behalf of the new vehicle's investors, which often include a mix of new LPs and rolling LPs from the old fund. This dual role creates significant questions about the fairness of the transaction, particularly regarding the valuation of the asset being transferred.

Regulators are likely examining whether the sale price maximizes returns for the LPs in the selling fund or if it is priced advantageously for the new vehicle, where the GP often structures more favorable economic terms for itself. The valuation process is typically managed with input from third-party advisors, but the ultimate decision-making power rests with the GP, creating a potential for biased outcomes. Fee structures are another area of focus, as the creation of a CV allows the GP to generate a new stream of management fees and carried interest, prolonging their economic relationship with the asset.

In our experience, the valuation process in a GP-led secondary transaction like a continuation vehicle is the single most critical point of failure or success. The general partner is negotiating with itself, which demands an exceptionally rigorous and independent valuation to protect all parties. For the leadership of a mid-sized company being transferred into a CV, understanding this process is vital to ensuring the new ownership structure is stable and equitable. This is precisely the kind of complex transaction where our capital raising and investor strategy services become critical. We help clients navigate these intricate structures to ensure fairness and transparency in valuation and governance. For guidance on these matters, business leaders can contact C&S Finance Group LLC at csfinancegroup.com.

The decision for an investor to roll over into a new vehicle or cash out is a significant one, and it hinges entirely on the quality of the information provided by the general partner. We advise clients to demand full transparency on both the valuation methodology and the revised fee arrangements in the new fund.

For the mid-sized companies at the center of these deals, the creation of a continuation vehicle can be a double-edged sword. On one hand, it provides continuity of ownership and continued access to the GP's resources and strategic guidance. It avoids the disruption of a full sale to a new owner with a different vision. On the other hand, it extends the timeline to an ultimate exit, potentially delaying a liquidity event for founders and management teams who hold equity in the business. The terms of the new vehicle can also alter governance and incentive structures within the company.

The SEC has previously signaled its focus on the private fund industry, particularly regarding transparency, fees, and conflicts of interest. In 2022, the commission proposed a set of new rules for private fund advisers that included mandates for fairness opinions in GP-led secondary transactions like CVs. While those rules are still being finalized, this new investigation indicates the agency is not waiting for formal rulemaking to examine current market practices.

The outcome of the SEC's probe is not yet known, but market participants will be watching closely for any enforcement actions or official guidance that may emerge. The investigation could lead to increased pressure on private equity firms to adopt more standardized and transparent valuation processes, enhance disclosures to investors about conflicts of interest, and provide more robust justification for the fees associated with these vehicles. Any resulting changes could significantly reshape this increasingly important corner of the capital raising landscape.